Apollo Hospitals has quietly acquired Onco.com, a cancer‑care aggregator founded in 2016, planning to integrate its digital ...

Founded by Jain and Dr Amit Jotwani in 2016, Onco raised $13 Mn in funding from investors like Accel, Rainmatter, Alteria ...

Onco acted as an aggregator platform for hospitals and provided online consultancy services for cancer patients. It also ...

Agilus Diagnostics validates and rollout D-DISH test for HER2 equivocal cases: Our Bureau, Mumbai Thursday, July 10, 2025, 11:45 Hrs [IST] Agilus Diagnostics, India’s largest ne ...

VANCOUVER, BC / ACCESS Newswire / July 4, 2025 / Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H,WKN: A3EKSZ) ("Onco" or the "Company") is pleased to announce that it has entered ...

VANCOUVER, BC / ACCESS Newswire / July 2, 2025 / Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H,WKN:A3EKSZ) ("Onco" or the "Company") is pleased to announce that on July 2, 2025, ...

Onco-Innovations inks agreement with Nucro-Technics for IND-enabling studies: Vancouver, Canada Tuesday, July 8, 2025, 10:00 Hrs [IST] Onco-Innovations Limited, a Canadian-based c ...

Onco-Innovations is a Canadian-based company dedicated to cancer research and treatment, specializing in oncology. Onco's mission is to pursue the prevention and treatment of cancer through ...

West Bengal- West Bengal University of Health Sciences (WBUHS) has opened the online registration portal for the Post ...

Onco-Innovations is a Canadian-based company dedicated to cancer research and treatment, specializing in oncology. Onco's mission is to pursue the prevention and treatment of cancer through ...

Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a biotech company focused on difficult-to-treat cancers, today announces the net sales for the second quarter of 2025. Oncopeptides ...

Onco-Innovations views this Expression of Interest as a strong validation of the PROmAI initiative's relevance and potential impact in the rapidly evolving field of oncology R&D. The Company remains ...